THOPAVIMA
ActiveSummary
THOPAVIMA has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €270,703 and a net result of €25,954. Equity is growing by about 3.9% per year across the filed financial years. Its solvency ranks better than 55% of 16,933 sector peers (NACE 68, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
07-04
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
30-09
Financial
Highest result from 2019 to 2025net €25,954 ▲7%
Net result €25,954, the highest in the series.
25-04
NBB filing
Annual accounts filed
financial year 2024 · micro format
2023
15-12
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
07-04
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format
2022
11-04
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format
2021
30-09
Financial
Back to profitnet €8,105
Net result €8,105 after one loss-making year.
02-04
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format
2020
30-09
Financial
Weakest financial yearnet -€15,201
Net result drops to -€15,201, the lowest in the series; recovery starts the following year.
29-05
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format · 29 days late
2019
31-05
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format · 31 days late
2018
15-03
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format
2017
19-04
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 13 annual accounts filed, the latest 10 are here; all 13 are under Financials.
0 of 3 deeds read
About the unread acts
We know of 3 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.